Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,056 | -154,536 | -121,800 | -81,669 | -37,908 |
| Depreciation Amortization | 632 | 5,648 | 4,539 | 3,286 | 1,637 |
| Accounts payable and accrued liabilities | 631 | 845 | -543 | 3,216 | 1,437 |
| Other Working Capital | 3 | 15,849 | 12,233 | 8,216 | 927 |
| Other Operating Activity | 5,378 | 24,103 | 15,955 | 9,143 | 4,978 |
| Operating Cash Flow | $-22,412 | $-108,091 | $-89,616 | $-57,808 | $-28,929 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,618 | 153,536 | 151,117 | 125,925 | 88,757 |
| PPE Investments | -85 | -11,816 | -11,631 | -10,807 | -4,374 |
| Investing Cash Flow | $21,533 | $141,720 | $139,486 | $115,118 | $84,383 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 610 | 365 | 365 | 3 |
| Other Financing Activity | 0 | -3 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $607 | $365 | $365 | $3 |
| Beginning Cash Position | 70,934 | 36,698 | 36,698 | 36,698 | 36,698 |
| End Cash Position | 70,055 | 70,934 | 86,933 | 94,373 | 92,155 |
| Net Cash Flow | $-879 | $34,236 | $50,235 | $57,675 | $55,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,412 | -108,091 | -89,616 | -57,808 | -28,929 |
| Capital Expenditure | -85 | -11,816 | -11,631 | -10,807 | -4,374 |
| Free Cash Flow | -22,497 | -119,907 | -101,247 | -68,615 | -33,303 |